famotidine has been researched along with Obstructive Lung Diseases in 4 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
| Excerpt | Relevance | Reference |
|---|---|---|
| "4 mg/kg as an intravenous infusion over 5 min (a dosage previously used to test drug interactions with cimetidine and ranitidine) were evaluated in 7 patients with chronic obstructive pulmonary disease (COPD) and peptic ulcer disease before and after 8 days' treatment with famotidine 40mg at night." | 3.68 | Famotidine and theophylline pharmacokinetics. An unexpected cimetidine-like interaction in patients with chronic obstructive pulmonary disease. ( Dal Negro, R; Pomari, C; Turco, P, 1993) |
| "Theophylline was infused after the 17th dose of each treatment." | 2.68 | Controlled study of the putative interaction between famotidine and theophylline in patients with chronic obstructive pulmonary disease. ( Bachmann, K; Jauregui, L; King, JD; Miller, K; Reese, JH; Schwartz, J; Scott, M; Stepanavage, M; Sullivan, TJ; Yeh, KC, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bachmann, K | 1 |
| Sullivan, TJ | 1 |
| Reese, JH | 1 |
| Jauregui, L | 1 |
| Miller, K | 1 |
| Scott, M | 1 |
| Yeh, KC | 1 |
| Stepanavage, M | 1 |
| King, JD | 1 |
| Schwartz, J | 1 |
| Dal Negro, R | 1 |
| Pomari, C | 1 |
| Turco, P | 1 |
| Asamoto, H | 1 |
| Kokura, M | 1 |
| Kawakami, A | 1 |
| Sawano, T | 1 |
| Sasaki, Y | 1 |
| Kohara, N | 1 |
| Kitamura, Y | 1 |
| Oishi, T | 1 |
| Morishita, H | 1 |
| Verdiani, P | 1 |
| Di Carlo, S | 1 |
| Baronti, A | 1 |
2 trials available for famotidine and Obstructive Lung Diseases
| Article | Year |
|---|---|
Controlled study of the putative interaction between famotidine and theophylline in patients with chronic obstructive pulmonary disease.
Topics: Adult; Aged; Cimetidine; Cross-Over Studies; Drug Interactions; Famotidine; Female; Humans; Infusion | 1995 |
Famotidine effects on theophylline pharmacokinetics in subjects affected by COPD. Comparison with cimetidine and placebo.
Topics: Aged; Cimetidine; Famotidine; Female; Half-Life; Humans; Lung Diseases, Obstructive; Male; Metabolic | 1988 |
2 other studies available for famotidine and Obstructive Lung Diseases
| Article | Year |
|---|---|
Famotidine and theophylline pharmacokinetics. An unexpected cimetidine-like interaction in patients with chronic obstructive pulmonary disease.
Topics: Cimetidine; Drug Interactions; Famotidine; Humans; Infusions, Intravenous; Lung Diseases, Obstructiv | 1993 |
Effect of famotidine on theophylline clearance in asthma and COPD patients.
Topics: Adult; Aged; Asthma; Famotidine; Female; Histamine H2 Antagonists; Humans; Lung Diseases, Obstructiv | 1987 |